What is Linda Woodson's NPI number?

Linda Woodson's National Provider Identifier (NPI) is 1972682664, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Linda Woodson's specialty?

Linda Woodson is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Linda Woodson located?

Linda Woodson's practice location on file with NPPES is 2800 N Tenaya Way Ste 203, Las Vegas, NV 89128-1100.

What is Linda Woodson's phone number?

The practice phone number listed in the NPPES registry for Linda Woodson is (702) 202-2700.

Does Linda Woodson accept Medicare?

Linda Woodson is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Linda Woodson's NPI active?

Yes — Linda Woodson's NPI (1972682664) is active in the NPPES registry as of the last update on 2015-01-28.

IndividualActiveAccepts Medicare

Linda Woodson, M.D.

NPI 1972682664 · Dermatology Physician · Las Vegas, NV

Linda Woodson, M.D. is a Dermatology Physician provider in Las Vegas, NV (NPI 1972682664).

Provider details

NPI number: 1972682664
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Female
Sole proprietor: No
License: 7012 (NV)

Practice location

2800 N Tenaya Way Ste 203

Las Vegas, NV 89128-1100

Phone: (702) 202-2700

Fax: (702) 307-5480

Street-level locationGet directions

More NV providers

Mailing address

2800 N Tenaya Way Ste 203

Las Vegas, NV 89128-1100

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 7012 (NV)
Allopathic & Osteopathic Physicians
Dermatology Physician207N00000XLicense G072603 (CA)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(79/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
20 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
3,027 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,111	$7
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	756	$93
Destruction of Precancer Skin Growth, 1 Growth17000	295	$51
Destruction of Skin Growth, 1-14 Growths17110	279	$116
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203	115	$115
Biopsy of Related Skin Growth, First Growth

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 35 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Triamcinolone Acetonide	241	138
Clobetasol Propionate	157	73
Betamethasone Dipropionate	125	83
Ketoconazole	106	53
Doxycycline Hyclate	81	34
Fluocinonide	78	47
Hydrocortisone	70	45
Mupirocin	64	39

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,579 across 157 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-11-03
Last updated: 2015-01-28

Frequently asked questions

What is Linda Woodson's NPI number?: Linda Woodson's National Provider Identifier (NPI) is 1972682664, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Linda Woodson's specialty?: Linda Woodson is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Linda Woodson located?: Linda Woodson's practice location on file with NPPES is 2800 N Tenaya Way Ste 203, Las Vegas, NV 89128-1100.
What is Linda Woodson's phone number?: The practice phone number listed in the NPPES registry for Linda Woodson is (702) 202-2700.
Does Linda Woodson accept Medicare?: Linda Woodson is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Linda Woodson's NPI active?: Yes — Linda Woodson's NPI (1972682664) is active in the NPPES registry as of the last update on 2015-01-28.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,111	$7
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	756	$93
Destruction of Precancer Skin Growth, 1 Growth17000	295	$51
Destruction of Skin Growth, 1-14 Growths17110	279	$116
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More99203	115	$115
Biopsy of Related Skin Growth, First Growth

Drug

Part D claims (2024)

Beneficiaries

Triamcinolone Acetonide

241

138

Clobetasol Propionate

157

Betamethasone Dipropionate

125

Ketoconazole

106

Doxycycline Hyclate

Fluocinonide

Hydrocortisone

Mupirocin

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$2,579 across 157 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments